Description of Event or Problem · 1
THIS PRODUCT MEETS THE CRITERIA FOR A 5-DAY MDR AS DESCRIBED IN THE FDA'S NOTICE DATED APRIL 8, 2008 [TO MANUFACTURERS AND INITIAL DISTRIBUTORS OF MEDICAL DEVICES THAT MAY CONTAIN HEPARIN OR ARE HEPARIN - COATED], AND ABBOTT IS SUBMITTING THIS 5-DAY MDR. OUR INVESTIGATION INTO THIS EVENT IS ONGOING AND A SUPPLEMENTAL MDR WILL BE SUBMITTED AT THE CONCLUSION OF OUR INVESTIGATION. ON 04/24/2008, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER WHO REPORTED AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 21.75 NG/ML. SAME SAMPLE TESTED USING A LABORATORY SYSTEM YIELDED A RESULT OF 1.22 NG/ML. SECOND SAMPLE TESTED USING AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 20.81 NG/ML. ON A DIFFERENT I-STAT INSTRUMENT, REPORTED AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 22.96 NG/ML. SAME SAMPLE TESTED USING A LABORATORY SYSTEM YIELDED A RESULT OF 1.44 NG/ML. THIRD SAMPLE TESTED USING AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 33.09 NG/ML. ON A DIFFERENT LOT NUMBER U08022 (2245578-2008-00028) REPORTED AN I-STAT CARDIAC TROPONIN I CARTRIDGE YIELDED A RESULT OF 27.11 NG/ML. SAME SAMPLE TESTED USING A LABORATORY SYSTEM YIELDED A RESULT OF 1.290 NG/ML.